Written Question·Department of Health and Social Care·UIN 24850

Bladder Cancer: Durvalumab

Tabled: 20 January 2025

Answered: 27 January 2025

Question

Jim Shannon

To ask the Secretary of State for Health and Social Care, what his planned timetable is for the rollout of Durvalumab for the treatment of bladded cancer.

Answer

Karin Smyth

The National Institute for Health and Care Excellence (NICE) makes recommendations on whether new medicines should be funded by the National Health Service based on their costs and benefits. Wherever possible, NICE aims to align its processes with the reg...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 24850) →